Synthesis of sk-membered nucleoside analogs. Part 1: Pyrimidine nucleosides based on the 1,3-dioxane ring system

Nucleosides and Nucleotides

Volumn 16, Issue 4, 1997, Pages 403-416

  Capaldi, Daniel C ^a   Eleuteri, Alessandra ^b   Chen, Qin ^c   Schinazi, Raymond F ^b  

^a Georgia Research Center for AIDS   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIOXANE DERIVATIVE; N 1 [(2 HYDROXYMETHYL) 1,3 DIOXAN 5 YL]CYTOSINE; N 1 [(2 HYDROXYMETHYL) 1,3 DIOXAN 5 YL]THYMINE; N 1 [(2 HYDROXYMETHYL) 1,3 DIOXAN 5 YL]URACIL; NUCLEOSIDE ANALOG; PYRIMIDINE NUCLEOSIDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRUS INHIBITION;

EID: 0030988278     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319708001358     Document Type: Article

References (24)

1. Mitsuya, H.; Weinhold, K. J.; Furman, P. A.; St. Clair, M. H.; Nusinoff-Lehrman, S.; Gallo, R. C.; Bolognesi, D.; Barry, D. W. and Broder, S. Proc. Natl. Acad. Sci. USA 1985, 82, 7096.
2. Elion, G. B.; Furman, P. A.; Fyfe, J. A.; de Miranda, P.; Beauchamp, L. M. and Schaeffer H. J. Proc. Natl. Acad. Sci. USA 1977, 74, 5716.
3. Nucleosides and Nucleotides as Antitumor and Antiviral Agents Eds. Chu, C. K. and Baker, D. C. Plenum Press, New York, 1992.
4. Beach, J. W.; Jeong, L. S.; Alves, A. J.; Pohl, D.; Kirn, H. O.; Chang, C.-N.; Doong,
5. L.; Schinazi, R. F.; Cheng, and Chu, C. K. J. Org. Chem .1992, 57, 2217.
6. Schinazi, R. F.; McMillan, A.; Cannon, D.; Mathis, R.; Lloyd, R. M.; Peck, A.; Sommadossi, J.-P.; St. Clair, M.; Wilson, J.; Painter, G; Choi, W.-B and Liotta, D. C. Antimicrob. Agents Chemother 1992, 36, 2423.
7. Kim, H. O.; Schinazi, R. F.; Nampalli, S.; Shanmuganathan, K.; Cannon, D. L.; Alves, A. J.; Jeong, L. S.; Beach, J. W.; Chu, C. K. J. Med. Chem., 1993, 36, 30.
8. Schinazi, R. F. Perspectives in Drug Development and Design, 1993, 7, 1151.
9. For the synthesis of other 6-membered nucleoside analogs see: (a) Augustyns, K.; Van Aerschot, A.; Urbanke, C. and Herdewijn, P. Bull. Soc. Chim. Belg. 1992, 707, 119.
10. (b) Augustyns K.; Rozenski, J.; Van Aerschot, A.; Janssen, G. and Herdewijn, P. J. Org. Chem. 1993, 58, 2977.
11. For recent examples see: (a) Jenny, T. F.; Schneider, K. C. and Benner, S. A. Nucleosides Nucleotides, 1992, 77, 1257.
12. (b) Perez-Perez, M.-J.; Rozenski, J.; Busson, R.; Herdewijn, P. J. Org. Chem. 1995, 60, 1531.
13. Kaiwar, V.; Reese, C. B.; Gray, E. J. and Neidle, S. J. Chem. Soc., Perkin Trans, l, 1995, 2282.
14. Wong, C. -H.; Garcia-Junceda, E.; Chen, L.; Blanco, O.; Gijsen, H. J. M. and Steensma, D. H. J. Am. Chem. Soc., 1995, 777, 3338.
15. Cruickshank, K. A.; Jiricny, J. and Reese, C. B. Tetrahedron Lett., 1984, 25, 681.
16. Hashiguchi, S.; Maeda, Y.; Kishimoto, S. and Ochiai, M. Heterocycles, 1986, 24, 2273.
17. Schreiber, S. L. and Wang, Z. Tetrahedron Lett., 1988, 29, 4085.
18. Pederson, B. S.; Scheibye, S.; Nilsson, N. H. and Lawesson, S.-O. Bull. Soc. Chim. Belg., 1978, 87, 223.
19. Starren, J. E.; Tortolani, O. R.; Baker, D. C.; Omar, M. T.; Hebbler, A. K., Wos, I. A.; Martin, J. C. and Mansuri, M. M. Nucleosides Nucleotides, 1990, 9, 885.
20. Eliel, E. L. and Knoeber, Sr. M. C. J. Am. Chem. Soc., 1968, 90, 3444.
21. Schinazi, R. F.; Sommadossi, J.-P.; Saalmann, V.; Cannon, D.; Xie, M.-Y.; Hart, G.; Smith, G.; Hahn, E. Antimicrob. Agents Chemother. 1990, 34, 1061.
22. Schinazi, R. F., Gosselin, G., Faraj, A., Korba, B. E., Liotta, D. C., Chu, C. K., Mathé, C., Imbach, J.-L. and Sommadossi, J.-P. Antimicrob. Agents Chemother. 1994, 38, 2172.
23. Schinazi, R.F., Scott, R., Peters, J., Rice, V. and Nahmias, A.J. Antimicrob. Agents Chemother. 1985, 28, 552.
24. Chou, T.-C.; Talalay, P. Adv. Enzyme Regul. 1984, 22,